C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2002
12/26/2002	US20020197674 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002	US20020197671 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002	US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis
12/26/2002	US20020197657 Apoptosis-related compounds and their use
12/26/2002	US20020197655 Antigen and monoclonal antibody which recognizes the antigen
12/26/2002	US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002	US20020197646 Single nucleotide polymorphisms associated with interstitial lung disease
12/26/2002	US20020197625 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection
12/26/2002	US20020197615 Nucleotide sequences coding polypeptide for use as diagnostic tool
12/26/2002	US20020197612 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects
12/26/2002	US20020197605 Novel Polynucleotides
12/26/2002	US20020197602 Nucleic acid sequences and proteins associated with aging
12/26/2002	US20020197270 Immunogenic compositions for induction of anti-tumor immunity
12/26/2002	US20020197266 Immunotherapy using interleukin 13 receptor subunit alpha 2
12/26/2002	US20020197262 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
12/26/2002	US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes
12/26/2002	US20020197259 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
12/26/2002	US20020197258 Compositions and methods for preventing protein aggregation in neurodegenerative diseases
12/26/2002	US20020197256 Combination therapy
12/26/2002	US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/26/2002	US20020197254 Soluble lymphotoxin beta receptor and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for treatment
12/26/2002	US20020197248 Method for treating a LFA-1-mediated disorder
12/26/2002	US20020197243 Novel p53BP2 compounds for therapy and diagnosis and methods for using same
12/26/2002	CA2391568A1 Collapsin response mediator protein-1
12/25/2002	CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002	CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity
12/25/2002	CN1387569A Apoptin-associating protein
12/25/2002	CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387536A T2R-novel family of taste receptors
12/25/2002	CN1386859A Coding sequence of arisaema agglutinant protein and its application
12/25/2002	CN1386856A Polypeptide-aconitase-8.8 and polynucleotide for coding it
12/25/2002	CN1386855A Polypeptide-zinc metal endonuclease-41.25 and polynucleotide for coding it
12/25/2002	CN1386853A Polypeptide-fatty acid enzyme-8.91 and polynucleotide for coding it
12/25/2002	CN1386852A Polypeptide-pyrophosphatase-8.91 and polynucleotide for coding it
12/25/2002	CN1386851A Polypeptide-human alcohol dehydrogenase III-51.37 and polynucleotide for coding it
12/25/2002	CN1386850A Polypeptide-glyceraldehyde-3-phosphate dehydrogenase-8.91 and polyncleotide for coding it
12/25/2002	CN1386762A Polypeptide-human macroprotein-51.37 and polynucleotide for coding it
12/25/2002	CN1386761A Polypeptide-human reverse transcription associated protein-14.08 and polynucleotide for coding it
12/25/2002	CN1386760A Polypeptide-olfactory receptor-10.78 and polynucleotide for coding it
12/25/2002	CN1386759A Polypeptide-elastatinal-43.12 and polynucleotide for coding it
12/25/2002	CN1386758A Polypeptide-human reverse transcription associated protein-15.07 and polynucleotide for coding it
12/25/2002	CN1386757A Polypeptide-leukemia associated protein 29.81 and polynucleotide for coding it
12/25/2002	CN1386756A Polypeptide-polypeptide chain surface receptor-38.28 and polynucleotide for coding it
12/25/2002	CN1386755A Polypeptide-glucoprotein-11.22 and polynucleotide for coding it
12/25/2002	CN1386751A Polypeptide-Pre-mRNA splicing factor-59.40 and polynucleotide for coding it
12/25/2002	CN1386749A Polypeptide-cotransporter-10.34 and polynucleotide for coding it
12/25/2002	CN1386748A Polypeptide-ribosomal L3 protein-9.68 and polynucleotide for coding it
12/25/2002	CN1386747A Polypeptide-histone H4-10.01 and polynucleotide for coding it
12/25/2002	CN1386746A Polypeptide-thermal shock protein-10.67 and polynucleotide for coding it
12/24/2002	US6498237 Induction of endhotelial procoagulant is inhibited and induction of fibrin deposition is enhanced; cytotoxicity and receptor binding activities unaffected; monoclonal antibody
12/24/2002	US6498236 Hybridoma cell culture supernatants, animal plasma or sera, or colostrum. the method includes the use of a minimum of salts, such as lyotropic salts, in the binding process and preferably also the use of small amounts of organic solvents in the
12/24/2002	US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/24/2002	US6498021 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-8 and uses thereof
12/24/2002	US6498014 Detecting peta-3 antigen for cancer diagnosis
12/24/2002	US6498008 Method for detecting swine infertility and respiratory virus
12/24/2002	US6498006 Administering mixture of liposome and drug
12/24/2002	US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	US6497878 Systemically administering amount of anti-interleukin-8 antibody effective to treat cerebral infarction
12/24/2002	US6497874 Modified filamentous phage which retains ability to bind and infect helicobacter pylori
12/24/2002	CA2147863C Determination of peptide motifs on mhc molecules
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/19/2002	WO2002101075A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002	WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	WO2002101040A1 Human-type anti-blood coagulation factor viii antibody
12/19/2002	WO2002101019A2 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100998A2 Method for generating diversity
12/19/2002	WO2002100901A2 Determination of bone-sialoprotein in bodily fluids for oncological problems
12/19/2002	WO2002100900A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	WO2002100897A2 Brca1/acc alpha molecular complexes, diagnostic and therapeutic applications
12/19/2002	WO2002100896A2 Method for diagnosing cancer susceptibility
12/19/2002	WO2002100890A2 Respiratory syncytial virus
12/19/2002	WO2002100432A1 Methods for the modulation of il-13
12/19/2002	WO2002100431A1 A pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100387A1 Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100343A2 N-terminally truncated galectin-3 and antibodies for treating cancer
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100326A2 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
12/19/2002	WO2002100248A2 Compositions and methods relating to glucose metabolism, weight control, and food intake
12/19/2002	WO2002100148A2 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002066603A3 Chemically defined medium for cultured mammalian cells

1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 1494